Document is current
Any future updates will be listed below
-
Authors
Lorenzi, Elena
Morello, Lucia
Giordano, Laura
Agostinetto, Elisa
Garassino, Isabella Maria Giovanna
Cavina, Raffaele
Mazza, Rita
Persico, Pasquale
Simonelli, Matteo
Carlo-Stella, Carmelo
Santoro, Armando
-
Funding
Funding for this research was provided by:
Amgen
AstraZeneca
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
Eisai
Genomic Health
Incyte
Merck Sharp and Dohme
Pfizer
Pharma Mar
Pierre Fabre
Roche
Sandoz
Sanofi
Teva Pharmaceutical Industries
- License Information
-
More Information
Article History
Received: 4 October 2021
Accepted: 30 January 2022
First Online: 7 February 2022
Declarations
:
: All procedures performed in studies involving humans were in accordance with the ethical standards of the institution or practice at which the studies were conducted. The study has been approved by the Ethics Committee of IRCCS Istituto Clinico Humanitas – Humanitas Cancer Center.
: All the participants signed an informed consent form.
: Not required as this manuscript does not include details, images, or videos related to the participants.
: The authors declare no competing interests.
